Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
|
1.Major complication of TPN therapy
|
A: systemic infection
|
|
|
2.Term refers to effects the drug has on the body
|
A: pharmocodynamics or pharmacodynamic phase
|
|
|
3.How to straighten ear canal when giving a child ear drops
|
A: down and backwards
|
|
|
4.How to straighten ear canal when giving adult ear drops
|
A: upward and out
|
|
|
5.Category of controlled substances used in health care facilities with high abuse potential
|
A: schedule II
|
|
|
6.Used to avoid irritating patients sensitive tissue
|
A: Z-track
|
|
|
7.Signs of mild allergic reaction
|
A: itching eyes and flushing
|
|
|
8.Controlled substance list on which are meds that have a low potential for abuse (cough relief meds, meds for diarrhea)
|
A: schedule V
|
|
|
9.The study of drug concentration during the process of absorption, distribution, biotransformation, and excretion
|
A: pharmacokinetic phase
|
|
|
10.Due to high concentration of solutes, most appropriate site for TPN infusion
|
A: central vein access
|
|
|
11.Medication administration route that can be used when IV access difficult and gastric absorption is ineffective
|
A: intraosseous
|
|
|
12Site that has fallen out of favor for IM injections
|
A: dorsogluteal
|
|
|
13.Hypotonic IV solution used for cardiac patient in heart failure
|
A: 5% dextrose water
|
|
|
14.Route of choice when patient has N/U
|
A: parental route
|
|
|
15.An example of plant source of medication
|
A: digoxin
|
|
|
16.Example of an incomplete drug order
|
A: Coumadin no route, Dig no route, MS name not spelled out
|
|
|
17.Frequency of change TPN tubing
|
A: every 24 hours
|
|
|
18.High potential for abuse medications such as heroin
|
A: schedule I
|
|
|
19.Sequence in which short acting regular insulin is mixed with long acting insulin
|
A: clean to cloudy
|
|
|
20.Amount of medication that can be given at one site
|
A: 3-4 mL
|
|
|
21.When wasting a narcotic
|
A: need signature of two licensed nurse
|
|
|
22.Preferred site for Z track and up to 3 mL of medication
|
A: ventrogluteal
|
|
|
23.Effects of primary drug increased
|
A: potentiation
|
|
|
24.Not used when patient has facial injuries
|
A: buccal route
|
|
|
25.Term used for “1st do no harm”
|
A: primun non nocere
|
|
|
26.Necessary test when TPN infusing
|
A: monitor glucose every 6 hours
|
|
|
27.Mineral source of medication
|
A: iron
|
|
|
28.Equipment used when infusing TPN
|
A: 0.22 micron filter
|
|
|
29Best way to achieve constant therapeutic drug level
|
A: intravenous route (continuous)
|
|
|
30.Oral prep that is fastest to be absorbed
|
A: liquids
|
|
|
31.Needed length for SC injection
|
A: 3/8” to 5/8” needle
|
|
|
32.Severe allergic reaction to meds
|
A: laryngeal edema, dyspnea
|
|
|
33.Use of placebo constitutes
|
A: fraud and deception
|
|
|
34.Medication administration route that bypasses blood brain barrier
|
A: intrathecal route
|
|
|
35.Elderly have an increased risk of drug toxicity due to
|
A: decreased serum albumen
|
|
|
36.Apply pressure over lacrimal duct when using eye drops
|
A: prevent systemic absorption
|
|
|
37.Animal or human source of medication
|
A: insulin
|
|
|
38.The study of ways drug forms disintegrate and dissolve or go into solution and become available for absorption
|
A: pharmaceutics
|
|
|
39.When giving insulin or Heparin
|
A: always verify dose with another dose
|
|
|
40.Occasion when enteric-coated medication cannot be used
|
A: via NG tube
|
|
|
41.Site for 1mL injection in are (deltoid)
|
A: 2 inches down from acromion process
|
|
|
42.Combined action greater than each drug alone
|
A: synergism
|
|
|
43.Decrease in response to either drug when 2 particular drugs are given together
|
A: antagonism
|
